What is BiotechBreakouts.com, Who is Kyle Dennis, and How Has He Made Over $3,000,000?
BiotechBreakouts.com is a leading educational platform and interactive community for stock traders. Within the stock trading space, these types of programs are often referred to as “newsletters” or “advisories”.
But before you go thinking that this is just another alert service that constantly sends out trade ideas without any explanation, let me be clear that this service isn’t like that. The primary focus is on education, which allows members to eventually become self-sufficient and consistently profitable as they learn to discover, track, and evaluate today’s hottest biotech stocks on their own.
Kyle Dennis is the founder of Biotech Breakouts and is one of the best active traders on Wall Street, hands down. Even at just 27 years old, he’s exponentially more qualified to teach biotech trading to his members due to his unmatched success. In less than five years, he’s taken a modest $15,000 starting portfolio and turned it into over $3,000,000.
I’ll give you a minute to name another trader that has been able to generate a similar percentage return…you probably can’t think of anybody, right? This type of ROI is virtually unheard of and probably seems unbelievable to most people. But it’s 100% legitimate, and I want to share with you exactly how he did it. Just like any high-quality offering, it’s all about transparency.
So go grab a pen and paper because you’re about to get an Inside Look at how Kyle Dennis turned a small portfolio into millions within just a few short years. It’s only a matter of time before some of his students hit the 7-figure profit mark as well under his expert education and guidance.
Why the Biotech Sector Offers Massive Profit-Potential and You Should Be a Part of It:
First, you need to extinguish from your mind the thought that the returns Kyle Dennis has been experiencing are “unrealistic”. People tend to have this misguided belief that anything over a 10-20% annual return is impossible, but that couldn’t be further from the truth.
In fact, it’s very possible to capture 100% or even 1,000%+ by pursuing an effective trading strategy within the right niche. In Kyle Dennis’ case, he’s achieved a 20,000% return in less than five years pursuing a strategy he calls Biotech Catalyst Swing Trading. His entire approach is covered within his most popular program – FDA Insider Alerts.
It’s clear that the biotech industry is special. Not only has it outperformed the S&P 500 by nearly 2x over the past five years (IBB up 135% and SPY up 69%), but it’s simply more exciting. Overall, it’s an industry with enormous upside.
Here Are 3 Specific Reasons Why:
1) Overall Trend of the Sector: With the aging US population, the demand for effective drugs for all sorts of conditions is rising. Baby boomers need medical care as they approach the later stages of life, and they’re far from the only group that requires medical care. Every demographic, including Generation X, Millennials, and Generation Z, is impacted by various ailments and diseases. This guarantees an influx of new patients for decades to come.
2) Demand For Breakthrough Technology: Healthcare has come to the forefront of our society, and as a result, the demand for new, more effective medications has been growing exponentially. Biotech companies are constantly developing new technologies to prevent and treat diseases. They’re on the verge of achieving tremendous feats like curing cancer and editing human genes. Just imagine what type of result that can have on a stock when these types of breakthroughs are achieved.
3) Structured Drug Approval Process: Every single biotech or pharma company that wants to bring a new drug to market has to go through the same process. There are 3 primary trial periods that can act as catalysts: Phase I, Phase II, and Phase III. I won’t go into detail about what each one is, but essentially, they take place in order to prove that a treatment or drug is effective. When an exciting new drug is going through this process, it can create ideal opportunities for traders. Biotech stocks can tend to run-up into big events, especially if it’s for a condition that doesn’t currently have a cure.
Success In Biotech Trading Involves Learning and Mastering the Catalysts:
The Catalysts are the key to massive profits, and the biotech sector has no shortage of them. In all reality, the industry is a gold mine for those willing to do a little homework and position themselves in trades with substantial upside potential and low downside risk. The right catalysts paired with bullish chart patterns and some fundamental research can take your small portfolio and turn it into a large one at a rapid pace.
|BioPharmCatalyst.com Review – A Database of Opportunities For Biotech Traders|
One of Kyle’s “Secret Tools” for tracking these high-potential events is a platform called BioPharmCatalyst. It’s essentially a database of opportunities for biotech traders and investors, and the Biotech Breakouts community takes full advantage of what it has to offer. Many of these catalysts have the ability to double your investment on good data or cut it in half on bad data, so the stakes are high. Holding through such events isn’t the goal though, it’s too risky. The run-ups into the events offer plenty of opportunities for relatively safe, yet larger-than-normal profits. It all comes down to knowing exactly what to look for.
The 3-Step Process Kyle Dennis Routinely Follows to Reduce Risk and Increase Profits:
I’ve mentioned most aspects of Kyle’s Biotech Catalyst Swing Trading strategy already, but I want to provide some clarity on the exact process he uses to research, consider, and ultimately execute profitable trades.
Step 1 – Identify a Strong Catalyst
A catalyst or event is a reason for a stock to move. It can be anything ranging from an upcoming earnings release to a potential acquisition. In biotech stocks specifically, the various stages of drug approval like Phase I, II, and II can provide extremely tradable opportunities. Over the years, Kyle has found Phase II and III to be his favorites. The deeper a drug goes into the trial process, the more excitement and positive sentiment seems to materialize.
He also prefers catalysts with exact dates, and for good reason. When you know exactly when data will be released, it provides a specific timeframe for executing the trade. In other words, you can enter and exit the trade without putting yourself at risk of holding through the event itself. Again, the goal is to capitalize on the run-ups for massive profits, while reducing downside risk as much as possible.
Step 2 – Pair With a Bullish Trend or Pattern
A strong catalyst alone can substantially move a stock, but pairing with a bullish chart pattern helps increase the odds of success even further. The more reasons you can accumulate to back up your trade thesis, the better. Putting the risk-reward ratio in your favor is critical.
There’s a lot to study on the concept of technical analysis, but Kyle tends to keep it simple. In short, he charts basic horizontal support & resistance lines, looking to enter at support and sell at resistance. Essentially, support is a price level where buyers historically tend to come in, and resistance is a price range where sellers tend to show up. Without technical analysis, it’s mighty difficult to plan out your trades in terms of entries and exits. There are only a few reversal and momentum patterns that he looks for, so it’s simple for anybody to understand.
Step 3 – Perform Fundamental Research
The last step is to make sure the company is fundamentally sound. This step isn’t as important as it would be for long-term investors, for example, but even with 1-4 week hold times, you don’t want to get stuck in a Secondary Offering. This happens when a company doesn’t have enough money to fund operations, so they have to raise more through a financing. It’s not always a bad thing assuming the company uses the money to grow, but in the short-term it dilutes share price.
What Kyle does to avoid such situations is research cash position and burn rate. By doing so, he sidesteps one of the biggest risks associated with trading stocks. Lots of uninformed traders don’t look into these things, but Kyle does. He also digs into the company’s management team and how they’re compensated, press releases, drug pipelines, SEC filings, and more. Overall, he wants the trades he enters to be as safe as possible.
Real Examples of Biotech Catalyst Swing Trades:
Here’s where the money is made! These are real-life examples of Biotech Catalyst Swing Trades. Hopefully this provides you with a comprehensive view of how all these concepts come together. We’re talking about relatively short-term trades with massive upside potential and low downside risk. No holding through the events themselves. The run-ups provide plenty of opportunity by themselves.
ZGNX (Zogenix, Inc.)
Earlier this year, I started tracking ZGNX as it appeared on one of Kyle’s daily watch lists. It had solid support in the $8.00 range and an upcoming catalyst event (Phase II data to be released on one of their drugs) at some point in Q2. Plenty of cash so the likelihood of an offering was low. Some well-known institutional investors like Baker Brothers and Black Rock also held positions, which is typically a good sign. I was able to capture 13% on a Move From $8.40 to $9.50, and then another 10% on a Move From $9.19 to $10.25. A clear reversal pattern was beginning to form as I entered and ended up exiting for a massive 20%+ gain in roughly 1-2 weeks.
IMMU (Immunomedics, Inc.)
After being in Kyle’s service for over a year now, I know exactly what types of setups to look for without his help. I scouted IMMU on my own and Captured 6% on an Overnight Hold. It had much more strength to the upside following my exit, but it’s hard to pass up over 5% within a day. Having to decide when to take profits is a good problem to have. On 8/22, I noticed that this stock had been up-trending throughout the entire year, and with Phase II data due in early September, I figured we might have a run-up on our hands heading into the event. I entered my position on 8/23 at $9.55 and exited on 8/24 at $10.15 for a solid 6% gain. It eventually surpassed $12 just a few days later. Overall, it had over 30% profit potential within a couple weeks.
I can go on-and-on with the examples, but the point is that there are a ton of opportunities within the biotech sector on a daily, weekly, and monthly basis. Massive profits can be achieved while also keeping risk relatively low. It’s a volatile space to be in, but when you understand how it all works, you can put the odds in your favor on a consistent basis.
Best of all, it doesn’t matter if trial data is good or bad, or even if the companies you trade stay in business long-term. The profits are made on the run-ups into big events, simple as that. You enter, exit, and secure your profits within 1-4 weeks all before the events themselves even take place.
Service Offerings at Biotech Breakouts – Lightning Alerts, FDA Insider Alerts, and Nucleus:
Kyle Dennis currently offers three different service offerings under his Biotech Breakouts platform: Lightning Alerts, FDA Insider Alerts, and The Nucleus. Here are short explanations of what each one is all about.
Lightning Alerts: This service is mainly chat-based, which is perfect for active day and swing traders. Both Kyle Dennis and Keith Kern (Keith is previously from Trader’s Toolbox) teamed up to offer a state-of-the-art chat room focused on “lightning-fast” profits. This particular service doesn’t discriminate against any industry or sector. Whatever stocks are moving and have momentum, they have their eyes on for a potential play. Both traders provide their own separate watch lists on a daily basis, focusing on carefully-researched stocks with optimal technical setups. They alert every trade they make and utilize real-money portfolios.
This service is best for → Active Day & Swing Traders.
FDA Insider Alerts: This service focuses on Kyle’s #1 strategy, Biotech Catalyst Swing Trading. This strategy is the main driver behind him being able to Turn $15,000 Into Over $3,000,000 in under five years. The focus is solely on biotech stocks with upcoming catalysts, and finding technical and fundamental setups to match. There’s no such thing as a “perfect” setup, but Kyle and his students are looking for a certain set of criteria. They attempt to isolate exciting events, position themselves in high-probability bullish chart patterns, and perform some fundamental background research in order to reduce risk. The ultimate goal is to capture massive gains on run-ups. These are typically 1-4 week hold times.
This service is best for → Busy Professionals & Swing Traders.
The Nucleus: This service is Kyle’s all-inclusive mentor service that provides access to Lightning Alerts, FDA Insider Alerts, and much more. The top feature of this program is Live Streaming Access to Kyle’s Portfolio, which allows for 100% transparency. It’s worth mentioning that there’s not many other traders out there willing to do this because they oftentimes have something to hide. Kyle, on the other hand, is willing to put every single move he makes on the table. In an industry full of “fakers” and “scam artists”, his complete transparency is refreshing. Overall, Kyle has a handful of strategies, or “profit buckets” as he likes to call them, that he implements in order to capture profits in the stock market, and this particular service uncovers all of them.
This service is best for → Committed Traders & Full-Time Traders.
Kyle Dennis’ Background and Track Record:
Kyle Dennis graduated from UCLA in 2012 with a degree in Biology. He incurred $80,000 in student loans and started working as a Real Estate Analyst making $35,000 per year. He was able to capture some solid profits trading part-time in 2013 and 2014, what many would consider a full-time income, but it wasn’t until 2015 when his profits exploded.
2013: $36,901 → 2014: $44,488 → 2015: $838,353 → 2016: $1,123,659 → 2017: $1,170,806 → 2018: $1,000,000+
It’s no surprise considering he joined an exclusive mentor service at that time being offered by Jason Bond. Kyle invested in himself and his own trading education, which eventually paid off thousands of times over. He took the concepts he learned from Jason and worked them into his own strategy within the biotech industry. He eventually quit his job that same year in order to pursue trading full-time. He then went on to launch his very own stock trading educational platform in 2016 – Biotech Breakouts. At this point in time (at only 27 years old), he’s making a consistent $1,000,000 per year in trading profits. Kyle’s Nucleus service resembles Jason’s Millionaire Roadmap.
Posts Featuring Kyle Dennis Before He Launched Biotech Breakouts:
|Millionaire Roadmap Client on Pace to Hit $1,000,000 in Trading Profits|
|Expert Stock Trading Mentor, Jason Bond, Awards Porsche to Millionaire Client|
|Millionaire Jason Bond Picks Client, Kyle Dennis, Launches Own Newsletter|
Special Bonus – Free Educational Webinars and E-Books From Kyle Dennis:
More than anything else, I want to help you find success in the stock market, and one of the best opportunities for free education is on Kyle’s Blog. He routinely records webinars on various topics related to his trading strategies and posts them for all to see. Members pay thousands of dollars for this material, in addition to daily watch lists, chat room access, special reports, and more, so these “freebies” provide an amazing opportunity for you to learn from the best biotech trader on Wall Street at no cost.
- September 8 Portfolio Summary Video
- Catalyst Trading and Charting Webinar Part 1
- Catalyst Trading and Charting Webinar Part 2
- Catalyst Trading and Charting Webinar Part 3
- Kyle’s Million-Dollar Biotech Playbook
Biotech Breakouts With Kyle Dennis Testimonials From Members:
Joining Kyle’s Biotech Breakouts service has revolutionized my trading experiences. As a new trader, I have learned so much from his educational material and from his live chats throughout the market hours. This especially has helped me tremendously as I learn what it takes to become a successful trader.
– Mario C.
Since upgrading to The Nucleus service I am up $4500 in two weeks of part time trading. Your chat room is extremely educational as you provide live Q&A commentary during the market. I feel confident that one day I will be able to do this for a living.
– Jose M.
Kyle, I want you to know that I appreciate and value the process of constructing trades that you are presenting. In my view, you take a calculated and patient approach to entering a trade & you are very patient & analytical about how you manage the trade. This reflects wisdom & experience, in my opinion.
– Bill W.
One of the things I so appreciate about you is the way you answer the same questions over and over without the least hint of impatience. Clearly, you have new people all the time and will get the same questions, but even so, you make each person feel like they are asking an important question that you are happy to address.
– Wanda H.
I signed up for BTB Nucleus program the day it was offered. Kyle spends all day in the chat room teaching. You have unrestricted access to get all of your questions answered. He will take time to discuss technicals, fundamentals, trade software, news programs, scanners, etc. I really enjoy this service, and it has led to some of my consistently highest success rates with a given trading technique. I intend to continue on with this service at the Nucleus level and highly recommend it to others.
– Heather M.
Make Biotech Catalyst Swing Trading Your “Go To” Strategy:
The greatest traders on Wall Street know how to gain an advantage. They put the odds in their favor and stick to a disciplined approach that allows them to capture profits on a consistent basis. They also tend to specialize, knowing that mastering a particular niche can be extremely lucrative. That’s exactly what Kyle Dennis has done with the biotech industry, and precisely how he’s been able to make millions in the market over the course of the last 5 years.
|Check Out the Original Biotech Breakouts With Kyle Dennis Review|
|3 Ways to Follow and Learn From Kyle Dennis (Millionaire Trader) For Free|
Most importantly, he’s willing to share his strategy with anyone willing to put the time and effort into it. He teaches a well-rounded strategy that took him a couple years to master, but it’s by far the most effective short-term swing trading strategy I’ve ever come across. There’s no reason why anybody can’t make this approach part of their normal routine. I can’t stress enough how many of his students have said that Kyle’s lessons allowed them to “turn a corner” in their trading. It’s time to see real results in your portfolio, and Biotech Breakouts can help you make it happen.
**2021 UPDATE** → Check Out My #1 Recommended Learning Program For Beginner and Intermediate Traders
Are You Ready to Fast-Track Your Trading Success With Kyle Dennis as Your Personal Mentor and Trading Coach? Get Started Now.
Written by Matt Thomas
Related Pages:
- BioTech Breakouts Review – Kyle Dennis Turned $15K Into Over $1M
- What is BioTech Breakouts? Capture Explosive Gains in Biotech Stocks
- Kyle Dennis’ Brokerage Account Now Streaming Live Within Biotech Nucleus
- How to Trade Biotech Stocks Successfully According to Kyle Dennis
- An Inside Look at How Kyle Dennis Turned $15K Into Nearly $2M
Thanks for the info. You really go into depth with this service. It seems like a great opportunity and a wonderful program to be a part of. I have been looking into trading and doing some research trying to see how it all works and what benefits it will bring to me. I have heard a lot of great things about it and think I will be getting into it sometime soon.
That’s great, Angelina! Just keep in mind that trading is a lot more difficult to master than most people initially expect. It takes a ton of hard work, dedication, and cultivation of the proper mindset, but yes, it can certainly produce a great deal of benefits over time. Kyle Dennis is one of the best and most transparent traders and teachers out there, and his programs provide a great deal of value to any individual willing to put the work in to achieve self-sufficiency and consistent profit in the markets. Take care!
I’ve always wanted to learn about stocks. I got to be honest though, I don’t know if I’d be comfortable profiting off of the sick. You made it simple to understand which is great for someone like me who is just learning about biotech stocks. I bookmarked the page. This is great advice. I’m going to be following Kyle’s blog now.
As someone new to investing, this seems somewhat intimidating. But at the same time, who doesn’t want to get returns like Kyle?!?!
Do you think this program is something a newbie to investing can wrap their head around? What does the learning curve look like?
If this isn’t the best place to start out, what would be your recommended first steps before moving to a program like this?
Thanks for any guidance you can provide!
I think Kyle’s Biotech Catalyst Swing Trading strategy is beginner-friendly and a fairly easy concept to understand, but that doesn’t mean trading overall is easy. To get to Kyle’s level of profits and consistency, it takes quite a bit of hard work and experience. He makes money using multiple strategies or “profit buckets” as he likes to call them, which include day and swing trading both stocks and options across many sectors. Sometimes certain strategies work better than others depending on various conditions in the market, so he’ll focus on the ones that work best at any given time. His services are a great place to start thanks to all of the free education he provides.
Its exciting to know that we are at an age where the technology is possible to do things like cure cancer ( possibly) but I believe it. I also believe that there is a lot of money to be made in these stocks. I don’t know how to wrap my hear around figuring out which stocks to buy or how to buy, or mainly who to trust. But from how you explained this program, I feel like Kyle Dennis will be able to translate to me, how to make the right choices in where I put my money in regards to biotech trading. With results potentially happening within weeks – sign me up! I would very much so like to cash in on this multi-million dollar opportunity!
Hi Sophia – it’s definitely hard to figure out who to trust in the stock trading space, but Kyle Dennis is one of the best mentors out there. There will always be detractors and naysayers for anyone running a service like this – that’s just the reality of it. But there’s no better trader/teacher combination out there right now in my opinion. Best of all is that he shares 100% of his Biotech Catalyst Swing Trading strategy for free within multiple webinars on his Blog and through his E-Book.
You won’t find many other individuals providing this amount of value for free to anyone willing to consume it. Then if you want to take your knowledge and skills to the next level, he offers a completely transparent mentorship service called Nucleus. During the day, he trades live (various strategies), runs Q&A sessions, teaches lessons, and live streams his E-Trade account. There’s no hiding behind any bad trades, good or bad. They’re all out in the open. Overall, it takes much more hard work and dedication to become a consistently profitable trader than most people realize, but there aren’t many other services out there that can measure up to BiotechBreakouts in terms of quality education and mentorship.
The best? Really? Being on his trial program I asked him number of questions and didn’t get a single proper response. Well obviously his support team is just people who knows nothing (unless you count this as a valid response: “Kyle is busy or travelling and has hundreds of clients”)…. Also I’ve been receiving his emails/recommendations for a couple of weeks and I’d say a) he didn’t get any reasons (except some catalyst dates in future) to enter the trades; b) many and I repeat many of his recommendations went wrong.
I do think he’s one of the best stock trading mentors out there, but he does have quite a bit of members. For that reason, he has a support team that filters through and answers most of his emails concerning website access, billing, and other support issues, but any questions pertaining to stock trading itself, Kyle Dennis should definitely be answering himself (in my opinion). If you don’t mind sharing, what were some of the questions you were looking for answers to and receiving those responses for? His best mentorship and training comes within his Nucleus program, which provides direct access to him through the chat room and a live stream of his accounts. As unfortunate as it sounds, I’m sure he prioritizes direct support to subscribers of that program.
As far as the recommendations go, which ones are you referring to? His daily watch lists contain a handful of tickers (10-20) with upcoming catalysts about a month or two away. They’re not necessarily recommendations to buy, but simply to watch and do your own background research on. Then create your plan based on his teachings and execute trades that you’re comfortable with. He doesn’t recommend that anyone blindly follow him into trades based on alerts, but rather do their own research and enter/exit trades at their own discretion. He personally has losing trades from time to time (and so will any trader), but proper risk management and discipline helps mitigate the losses. Sometimes the market isn’t all that conducive to swing trading, so a small sample size might not be the best reflection of his overall results. Recently (the past couple weeks), I’ve seen that he’s been day trading quite a bit and limiting his swing trading with all the volatility in the markets.
Kyle Dennis is a name that I’ve come across before. Actually, I’ve visited your site before and read about his story. It’s pretty inspiring and makes me want to instantly dive into biotech catalyst trading. It’s clearly a great field of opportunity if you know what you’re doing. The profit rates are relatively high and Kyle offers great guidance.
You’re exactly right, Tyler. Kyle’s been able to capitalize on profitable opportunities in the market over the last five years, and Biotech Catalyst Trading is one of his most effective strategies. The concept is truthfully rather simple, but it works over-and-over again. His catalyst-driven approach can actually be applied to stocks within any sector, but the biotech industry is one of the best due to the constant flow of drugs having to go through a specific approval process. This creates run-up opportunities into pharmaceutical conferences and data releases that can generate healthy returns for those who do the proper research and enter at the right times leading up to the events. He now implements multiple strategies within his overall approach that includes more than just biotech stocks, but this is his “bread and butter” strategy that he shares through his FDA Insider Alerts program.
Hello Matt,
This is an amazing article on Biotech Breakouts. I am new to the concept of swing trading, however, I think anyone would be interested in numbers like 20,000% ROI! You’d be crazy not to be interested in returns like that. Would you suggest Biotech Breakouts as an entry level trading program or would you recommend something else for someone starting out?
Hi Tiffany – I certainly think that the programs Kyle Dennis offers at Biotech Breakouts are effective for beginners (especially, The Nucleus), but I understand that cost and skepticism are a factor for most potential subscribers.
That’s why I think those with even a minor interest in what he has to offer should check out his Biotech Breakouts Blog first. Within it, he shares a ton of valuable educational information on trading concepts and even the particulars of some of his strategies completely free. He probably shares more free material on his approach than any other trader with a mentorship program out there. It’s probably not a financially smart move for him to do, but he actually wants to help people no matter what position they’re in – just starting out or even trading for a while with various levels of success. I think everyone has something they could learn from him and it’s refreshing to see someone with his level of trading success sharing high-quality information at no cost.
Hey Matt,
It seems like Biotechbreakouts is a trustworthy service. I read your article and checked the website and I really got motivatated in starting a trading carreer, too. I did some trading in the past, but I never had the courage to trade with my own money. I was too scared to lose it. As Kyle Dennis says: You need a good mentor to be successful. The next time maybe I should try trading with a mentor like Kyle at Biotechbreakouts to overcome my fear and become good at trading. Thank you.
Sergej
Hi Sergej – Kyle Dennis’ Success Story is certainly motivating. He’s only in his mid-20’s and well on his way to $4 million in cumulative trading profits. He’s also one of the best mentors out there, and there’s no doubt that quality mentors are critical to each individual trader’s success. Sure, you can go out and learn tons of information on your own, but you’ll have to weed out a lot of bad information and learn tough (expensive) lessons in the process. Most of the time, it’s best to learn from someone who has already been where you are, figured it out, and is willing to pass that knowledge and experience on to you.
That’s not to say that every subscriber will be successful – there’s no guarantee of that. Kyle can’t control how much time and work everybody puts into studying his lessons and applying them. But the reality is that the success rate of members skyrockets when they have the right mindset, are willing to learn, and constantly strive to improve their approach. There’s no secret formula to making money trading stocks. but the profitable ones will tell you it boils down to education, guidance, and discipline. Paper Trading is always a great place to build confidence and experience before risking real money. Take care!
Hi
Thanks for providing valuable knowledge. I used to invest in day trading services and tips provided by brokers or agents, but 60% of tips and alerts never worked, and as a result, I had lost too much money. Now I understand that rather than relying on the tips/alerts, one must be equipped with the proper training and knowledge.
Regards
Arun
Hi Arun – that’s exactly right. There’s so much more to trading than receiving some “hot alerts” or “hot tips”. It really takes a sound understanding of concepts like risk vs. reward, stop losses, position sizing, etc. in order to make smart choices for your own portfolio. The success of various trades/investments also depends on your own risk tolerance, personality, portfolio size, schedule, and preferences. For example, a stock that might be a great day trade (hold time of a day or less) might be an atrocious long-term investment, and vice versa. And if you don’t have the availability or desire to monitor the markets on a consistent basis, then day trading is most likely out of the question.
If you’re receiving short-term trade alerts and trying to act upon them without the availability to do so, then it’s just not going to work out. And even so, if you decide you want to follow somebody else into a trade, you have to have your own trade plan for it (exit strategy) and be responsible for the outcome. Never rely solely on alerts. There are just so many factors that need to be considered and there’s no “one-size-fit-all” trading strategy for everybody. Learning how to find opportunities and execute on them on your own is the ultimate value. Self-sufficiency should be every trader’s top priority. In the end, education and mentorship is the only route that will lead to consistent success over time.
At my age 64 years old, my nerves can’t take the ups and downs of the Biotech sector. I am already a member in what I consider a very good stock advisor company. I have several positions in safe Bonds and Dividend Stocks. If I would have known at the age of thirty what I know now, I would have joined Biotech Breakouts. and no doubt made a lot of money.
Hi Wayne. If you don’t mind me asking – what’s the stock advisor company you’re currently a part of? Just curious
Matt,
This review was very informative, especially for someone unfamiliar with the trading world (particularly, biotechnology). When I look at the biotech sector’s success, it becomes obvious that there is a science to the process.
The information you provided was insightful to me, as I’ve pondered testing the waters of stock trading. Admittedly, I’m not at the level of understanding Kyle Dennis’ strategy that you explained thoroughly.
What was most meaningful was process used:
-Following trends and chart patterns
-Following breakthrough technologies
-Targeting the structured drug approach (phase 1, 2, 3, etc.)